Table 5.

Registered ongoing trials on malaria treatment in pregnant women

Study	Country	Registration ID	intervention
Effective and safe treatment for malaria in pregnancy in India: a randomised controlled trial	India	CTRI/2009/091/001055TEMP	AS+SP, AS+MQ
Randomized trial of 3 artemisinin combination therapy for malaria in pregnancy (DMA)	Thailand	NCT01054248	AS+MQ, AL, DHA+PQ
Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria (PREGACT)	Burkina Faso, Ghana, Malawi, Zambia	NCT00852423	DHA-PQ, AS+MQ, AS+AQ, AL
Pharmacokinetics of mefloquine-artesunate in Plasmodium falciparum malaria infection in pregnancy	Burkina Faso	NCT00701961	MQ-AS (pregnant vs. non- pregnant)
ACT in pregnant women	Nigeria	PACTR2010020001862624	Experimental group: AS/AQ, control group AL
Efficacy, safety and tolerability of dihydroartemisinin- piperaquine for treatment of uncomplicated malaria in pregnancy in Ghana	Ghana	NCT01231113	Drug: AS-AQ Drug: DHA-PQ fixed-dose combination